Home Tags Prescription Drugs

Tag: Prescription Drugs

For men with advanced prostate cancer

ASCO: Relugolix Superior to Leuprolide in Advanced Prostate Cancer

And, enzalutamide improves median overall survival in nonmetastatic, castration-resistant prostate cancer
There seems to be no significant difference between a five- and 10-day course of remdesivir for patients with severe COVID-19 not requiring mechanical ventilation

Five-Day Course of Remdesivir Beneficial in Severe COVID-19

No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation
Worldwide more physicians are using remdesivir to treat COVID-19 patients

Remdesivir Use Growing Globally in COVID-19 Patients

Yet, most physicians believe it is only moderately effective, better used earlier than official guidelines recommend
The VA health system has stopped nearly all use of hydroxychloroquine to treat COVID-19 patients

VA Slashes Use of Hydroxychloroquine to Treat COVID-19 Patients

Prescribing reduced to just three prescriptions in the last week as new research highlights possible dangers
The treatment effects of early comprehensive disease-modifying pharmacological therapy are considerable for patients with heart failure with reduced ejection fraction

Disease-Modifying Drug Regimen May Offer Benefit in Heart Failure

Lower risk for cardiovascular death or hospital admission seen in HF with reduced ejection fraction
Hydroxychloroquine and azithromycin may have a serious adverse impact on the cardiovascular system

CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine

Risk increased for prolonged QT and/or ventricular tachycardia, including torsades de pointes
Patients initiating hemodialysis often are prescribed opioids and short-acting benzodiazepines

Benzodiazepines, Codispensed Opioids Common in Hemodialysis

Risk for mortality increased for those receiving short-acting benzodiazepines alone or with opioids
For adults hospitalized with COVID-19 with lower respiratory tract infection

Remdesivir Beats Placebo for Time to COVID-19 Recovery

Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
The World Health Organization has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.

WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients

In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
For patients with COVID-19 requiring hospitalization

Hydroxychloroquine Plus Macrolides No Benefit in COVID-19

Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia